NASDAQ:ARVN 18 November 2025

Arvinas (ARVN) Soars 14% as Investors Cheer Pipeline Reset and Jefferies Update

Arvinas shares surged over 14% to the low-$13 range on November 18, 2025, with trading volume far above average. The move followed a pipeline reset, FDA acceptance of vepdegestrant’s New Drug Application, and cost-cutting plans including a 15% workforce reduction. The stock remains well below its 52-week high of $27.

18 November 2025

NASDAQ:ARVN·Pharmaceuticals·Stock Market

Rolls-Royce Shares Face Mixed Outlook Amid Middle East War Impact
March 22, 2026, 6:07 AM EDT. Rolls-Royce (LSE: RR) shares slipped 10% over the past month after a strong rally. Geopolitical tensions in the Middle East have pushed energy prices higher, disrupting flights and the global economy. The company's defence division may see increased demand due to rising military budgets in Europe. Its work on mini-nuclear reactors offers long-term growth potential amid energy insecurity. However, aviation remains a key risk: disruption to flights reduces revenue from engine servicing contracts. British Airways' flight suspensions to Dubai highlight these challenges. The wider economic slowdown from elevated oil prices could further dampen air travel demand. Rolls-Royce's exposure to AI-driven demand via data centre power systems also faces uncertainty amid rising interest rates. The stock's valuation has corrected but remains elevated. Analysts suggest cautious, long-term investment amid mixed factors shaped by the evolving Middle East conflict.